ACURA PHARMACEUTICALS SECURES BRIDGE FUNDING

Acura Pharmaceuticals today announced that the Company has secured $1 million under a term loan agreement with Essex Woodlands Health Ventures V, L.P.; Care Capital Investments II, L.P.; Care Capital Offshore Investments II, L.P.; Galen Partners III, L.P.; Galen Partners International III, L.P.; and Galen Employee Fund III, L.P. The Loan is secured by a lien on all assets of the Company and its subsidiaries, bears an annual interest rate of 10 percent, and matures June 1, 2006.

()a href="http://www.primezone.com/newsroom/?d=80382" target="_blank">PrimeZone